Safety Assessment of Monosaccharides, Disaccharides, and Related Ingredients as Used in Cosmetics.


Journal

International journal of toxicology
ISSN: 1092-874X
Titre abrégé: Int J Toxicol
Pays: United States
ID NLM: 9708436

Informations de publication

Date de publication:
Historique:
entrez: 8 6 2019
pubmed: 7 6 2019
medline: 18 12 2019
Statut: ppublish

Résumé

The Cosmetic Ingredient Review Expert Panel (Panel) assessed the safety of 25 monosaccharides, disaccharides, and related ingredients and concluded these are safe in the present practices of use and concentration described in the safety assessment. Many of these ingredients are common dietary sugars, dietary sugar replacements, or very closely related analogs and salts; 7 of the ingredients are listed by the Food and Drug Administration as generally recognized as safe food substances. The most commonly reported cosmetic function is as a skin-conditioning agent; other commonly reported functions are use as a humectant or as a flavoring agent. The Panel reviewed the animal and clinical data included in this assessment, acknowledged that the oral safety of many of these ingredients has been well established, and found it appropriate to extrapolate the existing information to conclude on the safety of all the monosaccharides, disaccharides, and related ingredients.

Identifiants

pubmed: 31170840
doi: 10.1177/1091581818814189
doi:

Substances chimiques

Cosmetics 0
Disaccharides 0
Monosaccharides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

5S-38S

Auteurs

Monice M Fiume (MM)

1 Cosmetic Ingredient Review Senior Director, Washington, DC, USA.

Wilma F Bergfeld (WF)

2 Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

Donald V Belsito (DV)

2 Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

Ronald A Hill (RA)

2 Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

Curtis D Klaassen (CD)

2 Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

Daniel C Liebler (DC)

2 Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

James G Marks (JG)

2 Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

Ronald C Shank (RC)

2 Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

Thomas J Slaga (TJ)

2 Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

Paul W Snyder (PW)

2 Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA.

Lillian J Gill (LJ)

3 Cosmetic Ingredient Review Former Director, Washington, DC, USA.

Bart Heldreth (B)

4 Cosmetic Ingredient Review Executive Director, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH